Company / Interest Expense
ResMed Interest Expense History
FY2016-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$24.0M
FY2021
5-year range
$24.0M / $24.0M
FY2017-FY2021
Trend
-40.6%
vs FY2020
Sector context
#30 of 40
Health Care
What the data says
ResMed's interest expense of $24M is lower than 75% of companies in the Health Care sector (FY2021). Improved from $36M to $24M over the past 2 years.
Based on SEC 10-K filings.
$24M in FY2021 with a 5-year CAGR of +16.4%.
Improved from $36M to $24M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -5.4%
- 5-Year CAGR
- +16.4%
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 40This company $24.0M Sector average $332.7M
▼
-92.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +16.4%, indicating consistent growth.
- In FY2021, interest expense decreased 40.6% year-over-year.
- Ranks #30 out of 40 companies in the Health Care sector.
- Peak interest expense was recorded in FY2020.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $24.0M | -40.6% |
| FY2020 | $40.4M | +11.7% |
| FY2019 | $36.2M | +27.5% |
| FY2018 | $28.4M | +0.4% |
| FY2017 | $28.2M | +152.0% |
| FY2016 | $11.2M | +93.9% |
As of FY2021 · SEC 10-K · Updated Feb 28, 2026